CNS PHARMACEUTICALS INC (CNSP:NASDAQ)
$2.18 0.05 (2.3474%)
Analysed CNS PHARMACEUTICALS INC (CNSP:NASDAQ) News Sources
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
11-03-2026
yahoo.com
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
02-03-2026
yahoo.com
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
17-02-2026
yahoo.com
CNS Pharmaceuticals Issues Letter to Shareholders
27-01-2026
yahoo.com
CNS Pharmaceuticals Announces CEO Transition
17-12-2025
yahoo.com
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
17-11-2025
yahoo.com
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
10-11-2025
yahoo.com
CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap
13-09-2025
yahoo.com
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
03-09-2025
yahoo.com
IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
27-08-2025
yahoo.com
What is the current price of CNS PHARMACEUTICALS INC (CNSP:NASDAQ)?
The current price of CNS PHARMACEUTICALS INC (CNSP:NASDAQ) is $2.18.
CNS PHARMACEUTICALS INC (CNSP:NASDAQ) absolute price change since previous trading day?
The absolute price change of CNS PHARMACEUTICALS INC (CNSP:NASDAQ) since the previous trading day is $0.05.
CNS PHARMACEUTICALS INC (CNSP:NASDAQ) percentage price change since previous trading day?
The percentage price change of CNS PHARMACEUTICALS INC (CNSP:NASDAQ) since the previous trading day is 2.3474%.
What is the most recent average sentiment score for CNS PHARMACEUTICALS INC (CNSP:NASDAQ)?
The most recent average sentiment score for CNS PHARMACEUTICALS INC (CNSP:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for CNS PHARMACEUTICALS INC (CNSP:NASDAQ)?
The most recent sentiment for CNS PHARMACEUTICALS INC (CNSP:NASDAQ) is .
SEC-8K** Filing Available For CNS PHARMACEUTICALS INC (CNSP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.